H. Vriesendorp

发表

Recurrence of hodgkin's disease after indium‐111 and yttrium‐90 labeled antiferritin administration

B. Andersson, K. Dicke, H. Vriesendorp, 1997, Cancer.

Genetics of kidney allograft survival in dogs. I. Relevance of subregions of the major histocompatibility complex in recipients without immunosuppressive therapy.

A. Bijnen, H. Obertop, H. Vriesendorp, 1979, Transplantation.

Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in mice.

R. Freedman, P. Borchardt, H. Vriesendorp, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Evaluation of indium-111- and yttrium-90-labeled linker-immunoconjugates in nude mice and dogs.

J. Williams, P. Leichner, H. Vriesendorp, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Intraperitoneal radioimmunotherapy with human monoclonal IGM in nude mice with peritoneal carcinomatosis.

R. Freedman, P. Borchardt, H. Vriesendorp, 2000, Cancer biotherapy & radiopharmaceuticals.

Hematologic side effects of radiolabeled immunoglobulin therapy.

H. Vriesendorp, S. Quadri, B. S. Andersson, 1996, Experimental hematology.

Aims of conditioning.

H. Vriesendorp, 2003, Experimental hematology.

Preclinical evaluation of intravenously administered 111In- and 90Y-labeled B72.3 immunoconjugate (GYK-DTPA) in beagle dogs.

J. Williams, Y. Shao, P. Leichner, 1993, Nuclear medicine and biology.

Proposal for translational analysis and development of clinical radiolabeled immunoglobulin therapy.

R. Freedman, K. Jaeckle, D. Cromeens, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Intralesional radiolabeled human monoclonal IgM in human tumor xenografts.

R. Freedman, P. Borchardt, H. Vriesendorp, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prolongation of renal allograft survival in DLA tissue-typed beagles after third-party blood transfusions and immunosuppressive treatment.

A. Bijnen, H. Obertop, H. Vriesendorp, 1978, Transplantation.

Polyclonal 90Yttrium labeled antiferritin for refractory Hodgkin's disease.

S. Order, P. Leichner, J. Klein, 1989, International journal of radiation oncology, biology, physics.

Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results.

B. Andersson, M. Keating, K. van Besien, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01.

S. Order, P. Leichner, J. Klein, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease.

J. Armitage, P. Bierman, J. Vose, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Review of five consecutive studies of radiolabeled immunoglobulin therapy in Hodgkin's disease.

H. Vriesendorp, S. Quadri, J. Morton, 1995, Cancer research.

Biodistribution and tumor localization of 111In-labeled unmodified and modified F(ab')2 fragments of human monoclonal IgM (16.88) in a nude mouse model.

J. Klein, H. Vriesendorp, S. Quadri, 1995, Nuclear medicine and biology.

The Major Histocompatibility System of the Dog

M. Dorf, H. Grosse-wilde, H. Vriesendorp, 1977 .

Selection of reagents for human radioimmunotherapy.

O. Onyekwere, J. Williams, Y. Shao, 1992, International journal of radiation oncology, biology, physics.

Intralesional radioimmunotherapy with Yttrium-90-labeled human monoclonal IgM in nude mice bearing human tumor xenografts.

R. Freedman, P. Borchardt, H. Vriesendorp, 2004, Cancer biotherapy & radiopharmaceuticals.

Prediction of normal tissue damage induced by cancer chemotherapy

H. Vriesendorp, F. Vriesendorp, R. Vriesendorp, 2004, Cancer Chemotherapy and Pharmacology.

Minor Histocompatibility Systems in Dogs

A. Bijnen, H. Obertop, H. Vriesendorp, 1978 .

Role of total body irradiation in conditioning for bone marrow transplantation.

D. V. van Bekkum, H. Vriesendorp, 1980, Haematology and blood transfusion.

Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution.

E. Mellits, J. Wingard, R. Saral, 1988, Medicine.

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft‐versus‐host disease

B. Andersson, M. Keating, K. van Besien, 1997, British journal of haematology.

Hodgkin's disease: new possibilities for clinical research.

S. Order, H. Vriesendorp, 1989, International journal of radiation oncology, biology, physics.

Fractionated intravenous administration of 90Y-labeled B72.3 GYK-DTPA immunoconjugate in beagle dogs.

J. Williams, Y. Shao, H. Vriesendorp, 1993, Nuclear medicine and biology.

Intraperitoneal indium-111- and yttrium-90-labeled human IgM (AC6C3-2B12) in nude mice bearing peritoneal carcinomatosis.

R. Freedman, H. Vriesendorp, S. Quadri, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Tumor targeting and pharmacokinetics of unmodified and modified F(ab)2 fragments of an anti-CEA murine monoclonal antibody (Immu-14)

G. Griffiths, D. Goldenberg, H. Vriesendorp, 1995 .

Successful bone marrow transplantation across major histocompatibility barriers in rhesus monkeys.

G. Wagemaker, D. V. van Bekkum, H. Vriesendorp, 1981, Transplantation proceedings.

Radiolabeled immunoglobulin therapy in patients with Hodgkin's disease.

H. Vriesendorp, S. Quadri, 2000, Cancer biotherapy & radiopharmaceuticals.

Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies.

K. van Besien, S. Giralt, D. Przepiorka, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Liver toxicity induced by combined external-beam irradiation and radioimmunoglobulin therapy.

L. Stephens, C. Lollo, R. Bartholomew, 1995, Radiation research.

INTERSTITIAL PNEUMONITIS FOLLOWING AUTOLOGOUS BONE MARROW TRANSPLANTATION

E. Mellits, J. Wingard, H. Braine, 1988, Transplantation.

Tumor targeting and pharmacokinetics of unmodified and modified F(ab)2 fragments of an anti-CEA murine monoclonal antibody (Immu-14).

G. Griffiths, D. Goldenberg, H. Vriesendorp, 1995, Nuclear medicine and biology.

Assessment of radiolabeled stabilized F(ab')2 fragments of monoclonal antiferritin in nude mouse model.

Jerry R. Williams, J. Williams, H. Mohammadpour, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Influence of genetic resistance and silica particles on survival after bone marrow transplantation.

B. Löwenberg, D. V. van Bekkum, H. Vriesendorp, 1976, Transplantation Proceedings.

Prediction of effects of therapeutic total body irradiation in man.

H. Vriesendorp, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiobiological speculations on therapeutic total body irradiation.

H. Vriesendorp, 1990, Critical reviews in oncology/hematology.

Susceptibility to Total Body Irradiation

D. Bekkum, H. Vriesendorp, 1984 .

Radiobiology of total body radiation.

R. Champlin, P. Besa, T. Ochran, 1994, Bone marrow transplantation.

Value of the mixed lymphocyte reaction in dogs as a genetic assay

A. Bijnen, H. Vriesendorp, D. L. Westbroek, 1979, Immunogenetics.

Applications of transplantation immunology in the dog.

H. Vriesendorp, 1979, Advances in veterinary science and comparative medicine.

Improved survival of dogs exposed to fission neutron irradiation and transplanted with DLA identical bone marrow.

T. MacVittie, R. Monroy, H. Vriesendorp, 1987, Bone marrow transplantation.

JOINT REPORT OF THE THIRD INTERNATIONAL WORKSHOP ON CANINE IMMUNOGENETICS: II. ANALYSIS OF THE SEROLOGICAL TYPING OF CELLS

H. Deeg, R. Storb, E. Albert, 1987, Transplantation.

Factors controlling the engraftment of transplanted dog bone marrow cells.

D. V. van Bekkum, H. Vriesendorp, C. Zurcher, 2008, Tissue antigens.

Joint report of the Second International Workshop on Canine Immunogenetics.

M. R. Mickey, R. Storb, E. Albert, 1976, Transplantation proceedings.

Joint report of 1st International Workshop on Canine Immunogenetics.

H. Flad, L. Bernini, R. Saison, 1973, Tissue antigens.

Influence of DL-A matching, ALS, and 24-hour preservation on isolated pancreas allograft survival.

P. Hörchner, L. Verschoor, H. Vriesendorp, 1973, Transplantation Proceedings.

DELAYED ALLOIMMUNISATION BY RANDOM SINGLE DONOR PLATELET TRANSFUSIONS A Randomised Study to Compare Single Donor and Multiple Donor Platelet Transfusions in Cancer Patients with Severe Thrombocytopenia

B. Löwenberg, J. Abels, K. Sintnicolaas, 1981, The Lancet.

Alternatives to donor matching for control of graft-versus-host disease

T. Visser, H. Vriesendorp, C. Zurcher, 2004, Immunogenetics.

GENETIC ASPECTS OF CANINE MIXED LEUKOCYTE CULTURES

J. G. van den Tweel, A. Termijtelen, J. V. van Rood, 1974, The Journal of experimental medicine.

Major histocompatibility complex of the dog

H. Vriesendorp, 1973 .

Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation.

S. Piantadosi, L. Plotnick, M. Zahurak, 1992, Blood.

Radiation sensitivity of transplanted bone marrow cells.

H. Vriesendorp, J. Williams, 1988, Transplantation.

High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease.

S. Piantadosi, W. May, R. Ambinder, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia.

S. Piantadosi, J. Wingard, H. Braine, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumour Therapy with Radiolabelled Antibodies

P. Borchardt, H. Vriesendorp, S. Quadri, 1998, BioDrugs.

Mechanisms and avoidance of graft-versus-host disease.

G. Wagemaker, D. V. van Bekkum, H. Vriesendorp, 1979, Transplantation proceedings.

History of graft-versus-host disease.

H. Vriesendorp, P. J. Heidt, 2016, Experimental hematology.

Polygenic control of mixed lymphocyte reaction in dogs.

H. Grosse-wilde, A. Bijnen, H. Vriesendorp, 2008, Tissue antigens.

EFFECT OF PRIOR PARENTAL BLOOD TRANSFUSIONS ON THE SURVIVAL OF RENAL ALLOGRAFTS FROM A DLA‐IDENTICAL SIBLING

A. Bijnen, H. Obertop, H. Vriesendorp, 1978, Transplantation.

Effect of prior third-party blood transfusions on canine renal allograft survival.

J. Jeekel, A. Bijnen, H. Obertop, 1978, Transplantation.

Effect of subcutaneous injections of kidney donor blood on renal allograft survival in DLA-typed dogs.

A. Bijnen, H. Obertop, H. Vriesendorp, 1978, Transplantation.

THE EFFECT OF DONOR BLOOD ON RENAL ALLOGRAFT SURVIVAL IN DL‐A TISSUE TYPED BEAGLE LITTERMATES

J. Jeekel, H. Obertop, H. Vriesendorp, 1975, Transplantation.

Gastrointestinal decontamination of dogs treated with total body irradiation and bone marrow transplantation.

H. Vriesendorp, C. Zurcher, P. J. Heidt, 1981, Experimental hematology.

Secondary responses of alloantigen-primed dog lymphocytes.

G. Betton, A. Bijnen, H. Vriesendorp, 2008, Tissue antigens.

Identification of four MLC-specificities in the dog.

E. Albert, R. Wank, B. Netzel, 2008, Tissue antigens.

Genetics and transplantation immunology of the DLA complex.

A. Bijnen, D. V. van Bekkum, H. Vriesendorp, 1977, Transplantation proceedings.

THE PRODUCTION AND EVALUATION OF DOG ALLOLYMPHOCYTOTOXINS FOR DONOR SELECTION IN TRANSPLANTATION EXPERIMENTS

E. Bos, H. Vriesendorp, D. L. Westbroek, 1971, Transplantation.

A COMPARATIVE STUDY OF HETEROLOGOUS ANTI‐MOUSE LYMPHOCYTE AND ANTIMOUSE THYMO‐CYTE SERA PREPARED BY TWO DIFFERENT IMMUNIZATION METHODS

H. Vriesendorp, M. Wood, 1969, Transplantation.

Survival of patients with resistant Hodgkin's disease after polyclonal yttrium 90-labeled antiferritin treatment.

P. Leichner, J. Klein, H. Vriesendorp, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

INTERLEUKIN‐2 FOR PREVENTION OF GRAFT‐VERSUS-HOST DISEASE AFTER HAPLOIDENTICAL MARROW TRANSPLANTATION

R. Champlin, J. Gajewski, I. Khouri, 1994, Transplantation.

Radiolabeled immunoglobulin therapy: old barriers and new opportunities

H. Vriesendorp, S. Quadri, 2001, Expert review of anticancer therapy.

Lasting engraftment of histoincompatible bone marrow cells in dogs.

D. V. van Bekkum, H. Vriesendorp, C. Zurcher, 1981, Transplantation.

Analysis of the DL-A system in families and populations of healthy and diseased individuals.

H. Vriesendorp, J. D'Amaro, D. L. Westbroek, 1973, Transplantation Proceedings.

THE INFLUENCE OF DL-A HISTOCOMPATIBILITY ON THE FUNCTION AND PATHOHISTOLOGICAL CHANGES IN UNMODIFIED CANINE RENAL ALLOGRAFTS

H. van Urk, J. Silberbusch, H. Vriesendorp, 1972, Transplantation.

POLYMORPHISM OF THE DL‐A SYSTEM

J. V. van Rood, H. Vriesendorp, J. D'Amaro, 1972, Transplantation.

Histocompatibility in orthotopic heart transplantation in dogs.

K. Meeter, E. Bos, H. Vriesendorp, 1971, Transplantation Proceedings.

Histocompatibility and allograft rejection in canine smallbowel transplants. Evidence for the existence of a major histocompatibility locus in the dog.

H. Vriesendorp, D. L. Westbroek, R. Willighagen, 1971, Transplantation Proceedings.

RECIPROCAL INTERFERENCE OF HOST-VERSUS-GRAFT AND GRAFT-VERSUS-HOST-REACTIONS

D. Bekkum, H. Vriesendorp, 1986, The Lancet.

Engraftment of stem-cell-enriched bone marrow fractions in MHC-identical dogs after fractionated total-body irradiation.

E. Walma, D. V. van Bekkum, H. Vriesendorp, 1987, Transplantation.

IMMUNOGLOBULIN LEVELS IN DOGS AFTER TOTAL‐BODY IRRADIATION AND BONE MARROW TRANSPLANTATION

P. Johnson, T. Fey, R. Halliwell, 1985, Transplantation.

Nerve allografts and histocompatibility in dogs.

K. Mechelse, S. Stefanko, H. Vriesendorp, 1977, Journal of neurosurgery.

Immunogenetic markers in canine paternity cases.

H. Vriesendorp, D. L. Westbroek, B. D. Hartog, 1974, The Journal of small animal practice.

Engraftment of allogeneic dog bone marrow.

D. V. van Bekkum, H. Vriesendorp, C. Zurcher, 1975, Transplantation proceedings.

Fractionated radiolabeled antiferritin therapy for patients with recurrent Hodgkin's disease.

E. Askew, P. Borchardt, J. Lai, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Quantitative SPECT for indium-111-labeled antibodies in the livers of beagle dogs.

W. Hawkins, P. Leichner, J. Klein, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pharmacokinetics of radiolabeled polyclonal antiferritin in patients with Hodgkin's disease.

E. Askew, P. Borchardt, J. Lai, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

A review of the intravenous administration of radiolabeled immunoglobulin G to cancer patients. High or low protein dose?

H. Vriesendorp, F. Vriesendorp, F. J. Vriesendorp, 2003, Cancer biotherapy & radiopharmaceuticals.

Influence of SD and LD matching on kidney allograft survival in unrelated mongrel dogs.

J. G. van den Tweel, H. van Urk, H. Vriesendorp, 1975, Transplantation Proceedings.

Yttrium 90 polyclonal antiferritin therapy in patients with refractory end stage Hodgkin's disease

D. Podoloff, H. Vriesendorp, S. Quadri, 1994 .

Preclinical analysis of intraperitoneal administration of 111In-labeled human tumor reactive monoclonal IgM AC6C3-2B12.

R. Freedman, H. Vriesendorp, S. Quadri, 1995, Cancer research.

History of graft-versus-host disease.

H. Vriesendorp, P. J. Heidt, 2016, Experimental hematology.

Radiolabeled Immunoglobulin Therapy for Patients with Solid Tumors

M. Kap, H. Vriesendorp, R. Sayah, 2017 .